KFDA holds information session on foreign inspection of clinical trials in Korea

The Korea Food and Drug Administration (KFDA) on Wednesday held its information session at the Korea Pharmaceutical Manufacturers Association, in a bid to help local drug makers cope with the inspection by the U.S. Food and Drug Administration and European Medicines Agency (EMA), when Korean companies’ nonclinical and clinical trials are inspected by such foreign regulatory authorities.

The ...